ControversiesChallengesConsensus

MDR will be “the most devastating thing to happen to European healthcare since WW2”

2019-09-16T10:41:45+01:00

Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.

Patients “will bear the brunt of this hardship” says Jump, who […]

MDR will be “the most devastating thing to happen to European healthcare since WW2”2019-09-16T10:41:45+01:00

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

2019-09-06T16:03:07+01:00

Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the […]

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy2019-09-06T16:03:07+01:00

Highlights from the CX 2019 session, Paclitaxel: The last word

2019-09-06T16:04:24+01:00

The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]

Highlights from the CX 2019 session, Paclitaxel: The last word2019-09-06T16:04:24+01:00

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures

2019-09-06T16:05:44+01:00

Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.

Hayes talks about the accuracy of the device’s deployment around the thoracic […]

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures2019-09-06T16:05:44+01:00

With focal dissection repair, the Tack Endovascular System “returns control to the operator”

2019-09-06T16:08:00+01:00

Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about the “limitations of the current clunky stenting paradigm” and how the […]

With focal dissection repair, the Tack Endovascular System “returns control to the operator”2019-09-06T16:08:00+01:00

Durability of endovascular aneurysm repair and the NICE guidelines

2019-09-06T16:08:53+01:00

A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.

Opening the session, Stéphan Haulon and his team […]

Durability of endovascular aneurysm repair and the NICE guidelines2019-09-06T16:08:53+01:00

Optimising surveillance and reintervention strategy following elective EVAR

2019-09-06T16:09:48+01:00

Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session.

Optimising surveillance and reintervention strategy following elective EVAR2019-09-06T16:09:48+01:00

Medical device industry leaders call for three big changes to “devastating” EU MDR legislation

2019-06-07T17:21:40+01:00

Industry leaders say approximately 50% of all medical devices will be withdrawn from the market; around 30% of manufacturers will not survive and patients might be at risk as a result of the European Medical Device Regulation (EU MDR), which is described by some as the “most disruptive force to […]

Medical device industry leaders call for three big changes to “devastating” EU MDR legislation2019-06-07T17:21:40+01:00

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone

2019-09-06T16:10:43+01:00

Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone2019-09-06T16:10:43+01:00

Comprehensive innovation programme gives insights into the technologies of the future

2019-09-26T15:00:31+01:00

The CX Innovation Programme showcased technological developments happening in all areas of the Charing Cross Symposium: acute stroke, aortic, peripheral, venous, vascular access, and wound care. Additionally, a new “Dragons’ Den” winner was crowned.

In the first talk of the session, Lindsay Machan (Vancouver, Canada) talked about the lessons he had learnt from being a founder […]

Comprehensive innovation programme gives insights into the technologies of the future2019-09-26T15:00:31+01:00

TEVAR performed outside the IFU has “dramatically worse outcomes”

2019-09-06T16:11:31+01:00

Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]

TEVAR performed outside the IFU has “dramatically worse outcomes”2019-09-06T16:11:31+01:00

New MIMICS-2 trial data show helical stents provide durable treatment of diseased femoropopliteal arteries

2019-09-06T16:12:16+01:00

New data from the MIMICS-2 trial show the BioMimics 3D stent, which mimics natural vascular curvature, remains safe and effective for patients with symptomatic atherosclerotic disease of the femoropopliteal arteries two years after implantation.

Principal investigator Timothy Sullivan (Minnesota, USA) presented the two-year findings at this year’s Charing […]

New MIMICS-2 trial data show helical stents provide durable treatment of diseased femoropopliteal arteries2019-09-06T16:12:16+01:00

Multicentre dataset reveals the added value of diffusion-weighted imaging in TEVAR practice

2019-09-06T16:13:28+01:00

Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and the future role of diffusion-weighted magnetic resonance imaging (DW-MRI) in reducing stroke from endovascular repair. The multicentre dataset was presented at a Charing […]

Multicentre dataset reveals the added value of diffusion-weighted imaging in TEVAR practice2019-09-06T16:13:28+01:00

Endovascular repair matches open surgery for treatment of men with complex but low-risk aortoiliac disease using self-expanding covered stents

2019-04-18T17:16:33+01:00

Michele Antonello

Endovascular repair shortens hospital stay and has comparable outcomes to open surgery when balloon-expandable covered stents are used to treat low-risk male patients with complex aortoiliac lesions, new data show. Michele Antonello (Padua, Italy), described some of the study’s key results during a presentation at […]

Endovascular repair matches open surgery for treatment of men with complex but low-risk aortoiliac disease using self-expanding covered stents2019-04-18T17:16:33+01:00

0.018-inch drug delivery platforms are as effective as 0.035-inch devices

2019-09-06T16:14:14+01:00

Andrew Holden

Interventionists can confidently use lower profile drug delivery platforms, based on data that shows 0.018-inch guidewire devices are non-inferior to 0.035-inch guidewires. In a Podium 1st presentation at Charing Cross (CX) Symposium on Thursday, Andrew Holden (Auckland, New Zealand) said: “At 90 days, we can […]

0.018-inch drug delivery platforms are as effective as 0.035-inch devices2019-09-06T16:14:14+01:00

Live case of challenging thoracic endovascular repair demonstrated using virtual reality at CX

2019-09-06T16:15:25+01:00

Tilo Kölbel’s team, led on site in Hamburg, Germany, by Giuseppe Panuccio, successfully performed a thoracic endovascular aortic repair (TEVAR) on a 77-year old female patient with American Stroke Association (ASA) class III, and multiple aortic aneurysm disease with multiple aneurysms. The live case was viewed by […]

Live case of challenging thoracic endovascular repair demonstrated using virtual reality at CX2019-09-06T16:15:25+01:00

CX 2019: Highlights from the inaugural iWounds Workshop

2019-09-06T16:16:14+01:00

Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.

Edmonds discusses why “too many legs are being lost” and Serena talks […]

CX 2019: Highlights from the inaugural iWounds Workshop2019-09-06T16:16:14+01:00

Endoanchors add to therapy options for AAA

2019-04-18T10:09:07+01:00

Frank Arko

Using EndoAnchors to fix and seal endovascular aortic grafts is safe and effective for short-neck abdominal aortic aneurysm (AAA) patients, two-year data from the ANCHOR global registry have shown. Frank Arko (Charlotte, USA) presented the findings yesterday at CX Symposium in a podium first session, […]

Endoanchors add to therapy options for AAA2019-04-18T10:09:07+01:00

The impact of paclitaxel concerns on vascular access

2019-04-18T10:32:43+01:00

paclitaxel

As part of Wednesday’s CX Vascular Access Workshop in the Pillar Hall Learning Centre, there was a section of the programme on drug-coated balloon trial updates which ended with a panel discussion on whether peripheral vascular disease data is applicable to vascular access. The discussion […]

The impact of paclitaxel concerns on vascular access2019-04-18T10:32:43+01:00

EVAR with an iliac branch endoprothesis is safe and effective

2019-09-06T16:20:32+01:00

Fabio Verzini

Yesterday, during the Aortic Podium 1st session, Fabio Verzini (Turin, Italy) reported that endovascular aneurysm repair (EVAR) with an iliac branch endoprothesis (Gore) is safe and effective. He added that the procedure was associated with improved quality of life in the short term and […]

EVAR with an iliac branch endoprothesis is safe and effective2019-09-06T16:20:32+01:00

Virtual reality stimulates discussion at CX

2019-04-18T10:30:36+01:00

virtual reality

For the first time, the Charing Cross (CX) audience has been able to experience an array of virtual reality live cases in both the peripheral and aortic programmes. The virtual reality live streaming in 360° video, accompanied by a running commentary by the operator, provided a […]

Virtual reality stimulates discussion at CX2019-04-18T10:30:36+01:00

EVAR funding threatened, while strategy for safe, cost-effective repair is “just around the corner”

2019-04-18T09:59:05+01:00

The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the National Institute for Health and Care Excellence (NICE), set to go against widespread endovascular practice in recommending open repair over EVAR. In May […]

EVAR funding threatened, while strategy for safe, cost-effective repair is “just around the corner”2019-04-18T09:59:05+01:00

Vascular recruitment a “universal problem”: The global perspective

2019-04-18T10:04:27+01:00

Sophie Renton

Across the globe, vascular recruitment is struggling. This was the reason why delegates convened in the Upper Auditorium yesterday afternoon for a CX Highlight Session dedicated to the topic, where representatives from three continents explained exactly how and why the vascular specialty is experiencing this […]

Vascular recruitment a “universal problem”: The global perspective2019-04-18T10:04:27+01:00

Don’t miss: The influence of hyperglycaemia on spinal cord injury

2019-09-06T16:21:31+01:00

Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”

Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]

Don’t miss: The influence of hyperglycaemia on spinal cord injury2019-09-06T16:21:31+01:00